Gujarat Terce Laboratories (BOM:524314) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524314 Gujarat Terce Laboratories Ltd BOM:524314
44 GF Score
Price ₹36.78
! 4 Warning Signs
View Full Analysis

What is Gujarat Terce Laboratories Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Gujarat Terce Laboratories is: No Data: Cannot be evaluated.

Gujarat Terce Laboratories  (BOM:524314) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Gujarat Terce Laboratories Risk Assessment Related Terms

BOM:524314 vs ZTS: Risk Assessment Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Terce Laboratories's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gujarat Terce Laboratories Risk Assessment vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Terce Laboratories's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Gujarat Terce Laboratories's Risk Assessment falls into.


BOM:524314
44GF Score
Gujarat Terce Laboratories Ltd BOM:524314
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gujarat Terce Laboratories Business Description

Address Near Shivalik High-Street, Unit No. D/801-802 and 1202,The First, Behind Keshavbaug Party Plot, Vastrapur, Ahmedabad, GJ, IND, 380015
Gujarat Terce Laboratories Ltd is an Indian company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, syrup, and injections. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, antifungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash, Aziter, and others.
44GF Score

Get the complete analysis for BOM:524314

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹36.78
Price